Abstract: The present invention is directed to the combined administration of a thioester therapeutic agent (preferably of formula I) and at least one esterase inhibitor. Also provided are a pharmaceutical composition, package, and a kit comprising the aforementioned active ingredients, as well as a method for increasing the bioavailability of said thioester for the treatment and prophylaxis of a cardiovascular disorder.

Abstract: A method and to a system can be used for measuring electric voltages in batteries with a number of battery cells. A measuring circuit includes at least one digital analog converter that constitutes, in combination with a number of comparators, an analog digital converter to determine the electric voltages of the battery cells. The comparators compare a reference voltage generated by the digital analog converter with the electric voltage of the battery cells over a number of separate measuring channels to the individual battery cells.

Abstract: A method and to a system can be used for measuring electric voltages in batteries with a number of battery cells. A measuring circuit includes at least one digital analog converter that constitutes, in combination with a number of comparators, an analog digital converter to determine the electric voltages of the battery cells. The comparators compare a reference voltage generated by the digital analog converter with the electric voltage of the battery cells over a number of separate measuring channels to the individual battery cells.

Abstract: The present invention relates to a novel stable S-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate liposomal composition, a process for the preparation thereof and its use in the treatment of diseases.

Abstract: The present invention is directed to the combined administration of a thioester therapeutic agent (preferably of formula I) and at least one esterase inhibitor. Also provided are a pharmaceutical composition, package, and a kit comprising the aforementioned active ingredients, as well as a method for increasing the bioavailability of said thioester for the treatment and prophylaxis of a cardiovascular disorder.

Abstract: A nuclear power plant with a gas cooled high temperature reactor, installed in a prestressed concrete pressure vessel with the operational and decay heat removal systems. The prestressed concrete pressure vessel has a thermal protection system, with a thermal insulating layer and a liner cooling system. The liner cooling system, which is includes water carrying cooling pipes, which along with intermediate heat exchangers and cooling water pumps make up a closed intermediate cooling loop used for removal of the decay heat in case a failure of the decay heat removal systems. The elements of the invention assure an adequate water flow for the removal of decay heat in the liner cooling system in any situation, i.e. such that the decay heat may also be removed by natural convection. These element insure a sufficient driving pressure differences and minimize pressure losses in the intermediate cooling loop.